A study of university students has shown that certain skin problems, including alopecia and pruritis can be exacerbated by stress.
A study shows that prices of prescription dermatologic drugs have risen dramatically in the US, becoming less affordable as insurance companies increasingly restrict formularies.
University of Notre Dame researchers have discovered a compound that accelerates diabetic wound healing, which may open the door to new treatment strategies.
The combination of cobimetinib and Zelboraf® (vemurafenib) has been shown to extend the lives of previously untreated patients with advanced skin cancer to nearly two years (22.
Most topical treatments currently available are not evidence-based.Don't believe the hype when you see those creams and ointments promising to prevent or reduce pregnancy stretch marks.
Doctors have completed the most extensive face transplant to date, giving a 41-year-old man injured as a firefighter in 2001 a new face from a 26-year-old donor.
A new guideline aims to help Canadian physicians, nurses and pharmacists treat children and adults with acne, a disease that can severely affect quality of life.
A groundbreaking wound dressing for burns that changes color in response to infection could help in the fight against global antibiotic resistance.
US regulators have approved a drug combination - vemurafenib (Zelboraf) and cobimetinib (Cotellic) - for advanced melanoma that shows great promise in extending patients' lives.
Study confirms 'intermediate' disease stage between benign moles and malignancy.